The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

AVAILABLE

Study Classification

EXPANDED_ACCESS

Study Start Date

2016-12-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The incidence rates of thyroid cancers have increased in the past decade. Additionally, up to 68% of people have thyroid nodules. Consequently, a precise evaluation of thyroid nodules is very important and can avoid unnecessary biopsy of benign nodules. Shear wave elastography(SWE), a novel ultrasound-based elastographic method, is a new real-time, quantitative, operator-independent, and reproducible technique. Briefly, shear wave elastography uses a radiation force produced by an ultrasonic beam to stress tissues and ultrafast sonographic tracking techniques to measure the speed of shear waves. Based on the Young modulus formula, tissue elasticity can be derived from the shear wave propagation speed, and a real-time color-coded elastogram can be displayed, showing softer tissue in blue and stiffer tissue in red.

There are lots of research confirmed that SWE has a certain value in the diagnosis of thyroid carcinoma. These studies include prospective studies and retrospective studies, but both belong to a single center study. It has not been applied to the study of the multicenter of thyroid disease.

The main purpose of the study is to assess the performance of SWE for identification of benign and malignant thyroid nodules and calculate the optimal cutoff value for each parameter in multicenter study; the secondary purpose is to evaluate the application value of SWE for uncertain nodules by FNA.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Diagnostic Value of Shear Wave Elastography

NCT02150772

Thyroid Nodule

COMPLETED NA

Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study

NCT01880203

Thyroid Node Indeterminate Cytology Surgery Indication

COMPLETED NA

Thyroid Ultrasound Elasticity (TrUE) Imaging

NCT03307694

Cancer, Thyroid

COMPLETED

Multimodality US Based on Angio Planewave Ultrasensitive Imaging and Shear Wave Elastography to Evaluate the Malignancy Risk Value of Thyroid Nodules

NCT06530771

Multimoda Lultasound Thyroid Cancer Microvascular Classification

RECRUITING

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

NCT04614389

Thyroid Nodule

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SWE can prove the diagnostic performance in the differentiation of benign and malignant thyroid lesions

1. Main purpose

1. to assess the performance of SWE for identification of benign and malignant thyroid nodules in multicenter study;
2. calculate the optimal cutoff value for each parameter in multicenter study
2. Secondary purpose to evaluate the application value of SWE for uncertain nodules by FNA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Nodules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SWE

a novel ultrasound-based elastographic method, a new real-time, quantitative, operator-independent, and reproducible technique

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. the size of the lesion is between 0.5～4cm
2. the solid components in the lesion\>50%；
3. all patients perform FNA or surgery in one month after SWE examination

Exclusion Criteria

1. patients who are unwilling or unable to provide informed consent
2. Woman who is pregnant or breastfeeding;
3. Thyroid nodules with calcified which is beyond 1/2 diameter of lesion
4. patients who have history of surgery、FNA or thermal ablation in ipsilateral thyroid
5. patients who have serious cardiopulmonary diseases

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No